Full name
POLMED DIAGNOSTYKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.66.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
72.19.Z - Scientific research and development activities
85.59 - Other non-school forms of education, not classified elsewhere
86.21.Z - General medical practice
86.90.E - Healthcare
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,9 | 1,9 | 2 | 6,2 |
EBITDA | 5,8 | 5,7 | 5,5 | -3,8 |
Short time liabilities | 10,8 | 11,4 | 14,4 | 26 |
Equity capital | 7,8 | 9,3 | 10,7 | 14,7 |
Operating profit (EBIT) | 2,8 | 2,8 | 2,6 | -7,1 |
Assets | 44,2 | 45,3 | 48,4 | 6,8 |
Net profit (loss) | 1,9 | 1,5 | 1,4 | -10,3 |
Cash | 0,8 | 0,5 | 0,2 | -60,2 |
Net income from sale | 20 | 21,3 | 20,6 | -3,1 |
Liabilities and provisions for liabilities | 36,4 | 36 | 37,7 | 4,8 |
Working assets | 8,4 | 12,4 | 18,5 | 49,3 |
Depreciation | 3,1 | 2,9 | 2,9 | -0,7 |
% | % | % | p.p. | |
Profitability of capital | 24,3 | 16,3 | 12,8 | -3,5 |
Equity capital to total assets | 17,7 | 20,6 | 22,1 | 1,5 |
Gross profit margin | 9,5 | 9 | 9,9 | 0,9 |
EBITDA Margin | 29,1 | 27 | 26,8 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 196 | 196 | 254 | 58 |
Current financial liquidity indicator | 0.7829499840736389 | 1.089317798614502 | 1.2902066707611084 | 0,2 |
Net dept to EBITDA | 4.4542670249938965 | 4.015287399291992 | 4.112479209899902 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane